(4-Chlorophenyl)(pyridin-2-yl)methanol, 95.0%, 10g

Eicosanedioic acid, 98.0%, 25g

2-METHYL-6-NITROQUINOXALINE, 95.0%, 1g

3,5-Di-tert-butylcatechol, 98.0%, 100g

Sclareolide, 95.0%, 5g

[(4-isopropyl-4H-1,2,4-triazol-3-yl)methyl]amine dihydrochloride, 95.0%, 250mg

tert-Butyl (3R)-3-[3-bromo-4-carbamoyl-5-(methylamino)pyrazol-1-yl]pyrrolidine-1-carboxylate, 98%, 100mg

N-Methyl-N-(trifluoromethylthio)aniline>98.0%(GC)1g

2-Ethyl-6-methylphenyl isothiocyanate, 97.0%, 5g

5-Chloro-pyridine-2,3-dicarboxylic acid, 96%, 1g

5-(4-(4-(Prop-2-yn-1-yloxy)benzoyl)phenoxy)pentanoic acid, 97.0%, 1g

Colonna capillare per GC ROTI®Cap-1, 30 m, 0.32 mm, 5.00 µm, 1 Pezzo(i)

Ethyl 6-chloro-5-fluoropyrimidine-4-carboxylate, 98%, 250mg